Stocktoria
Trulieve Cannabis Corp. TRLV
NYSE · XNYS · stock · Medicinal Chemicals & Botanical Products · website · IPO 2018-09-25
Trulieve Cannabis Corp. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 60.2% | 60.3% | 52.1% | 56.6% | 60.8% |
| Operating margin | 12.1% | 8.2% | -19.6% | 4.1% | 21.9% |
| Net margin | — | — | — | -20.7% | 1.9% |
| FCF margin | 19.4% | 12.5% | 14.3% | -11.6% | -28.2% |
| Return on assets | — | — | — | -7.4% | 0.5% |
| Return on equity | — | — | — | -13.1% | 0.8% |
| Debt / equity | 0.12× | 0.29× | 0.26× | 0.28× | 0.22× |
| Current ratio | 4.43 | 4.37 | 4.16 | 2.82 | 3.10 |
| Revenue growth | -0.4% | 5.1% | -7.3% | 30.7% | 78.7% |
Source: SEC EDGAR filings · CIK 0001754195 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.